Physician profile
Gaurav J Patel
NPI 1952680332
$45,424.22
in general payments reported to CMS, 2019-2025
45 companies · $2,242 in 2025
The $2,242 reported for 2025 was more than what 88% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $6,748 · 2021: $4,763 · 2022: $3,612 · 2023: $6,940 · 2024: $2,415 · 2025: $2,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,517 · Education: $3,235 · Travel and Lodging: $1,845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,516.79 |
| Education | $3,235.10 |
| Travel and Lodging | $1,844.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $18,268.83 | 2019-2025 | Arikayce |
| Sunovion Pharmaceuticals INC. | $5,114.93 | 2019-2020 | |
| Intuitive Surgical, INC. | $4,898.88 | 2023 | Da Vinci Surgical System, Da Vinci Sp |
| Astrazeneca Pharmaceuticals LP | $3,230.32 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Inspire Medical Systems, INC. | $1,930.66 | 2022-2025 | Inspire |
| Glaxosmithkline, LLC. | $1,874.42 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Mylan Specialty L.P. | $1,534.93 | 2019-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $1,081.24 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $896.71 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $759.19 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Medtronic, INC. | $645.08 | 2021-2022 | |
| Harmony Biosciences LLC | $569.56 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $520.72 | 2019-2025 | Xywav |
| Grifols USA, LLC | $468.85 | 2019-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $453.17 | 2020-2025 | Aralast, Glassia |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $332.52 | 2019-2025 | Tyvaso, Tyvaso |
| Genzyme Corporation | $292.98 | 2019-2023 | |
| Axsome Therapeutics, INC. | $271.46 | 2023-2025 | Sunosi |
| Novartis Pharmaceuticals Corporation | $197.43 | 2019-2024 | |
| Mallinckrodt Enterprises LLC | $188.82 | 2019 | |
| Ani Pharmaceuticals, INC. | $188.38 | 2024-2025 | Purified Cortrophin Gel |
| Genentech USA, INC. | $184.00 | 2019-2020 | |
| Philips North America LLC | $176.18 | 2020-2025 | Vest Therapy Und |
| Electromed, INC. | $150.07 | 2023-2025 | Smartvest |
| Verona Pharma, INC. | $117.42 | 2025 | Ohtuvayre |
| Nabriva Therapeutics, Plc | $116.16 | 2021-2022 | |
| Advanced Respiratory, INC | $107.47 | 2020-2021 | |
| Avadel Cns Pharmaceuticals, LLC | $98.69 | 2024 | Lumryz |
| Sanofi-Aventis U.S. LLC | $93.76 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $83.07 | 2022 | |
| Viatris Specialty LLC | $67.82 | 2025 | Yupelri |
| Tactile Systems Technology INC | $63.96 | 2024 | Flexitouch Plus, Entre Plus |
| Mallinckrodt Hospital Products INC. | $60.36 | 2020 | |
| Circassia INC. | $59.23 | 2019-2020 | |
| Baxter Healthcare | $57.04 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Pulmonx Corporation | $51.40 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Bayer Healthcare Pharmaceuticals INC. | $38.91 | 2019 | |
| Resmed Corp | $34.54 | 2019-2024 | |
| Medtronic Vascular, INC. | $29.04 | 2019 | |
| Lilly USA, LLC | $22.32 | 2025 | Zepbound |
| Inogen, INC. | $21.16 | 2025 | |
| Amgen INC. | $19.79 | 2024 | Tezspire |
| Merck Sharp & Dohme LLC | $18.86 | 2021 | |
| Shire North American Group INC | $18.35 | 2019 | |
| Breas Medical, INC. | $15.54 | 2024 | Vivo 45 Ls |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.